Trogocytosis is an active transport mechanism by which one cell extracts a plasma membrane fragment with embedded molecules from an adjacent cell in a contact-dependent process leading to the acquisition of a new function. Our protocol, which has general applicability, consolidates and optimizes existing protocols while highlighting key experimental variables to demonstrate that natural killer (NK) cells acquire the tetraspanin CD9 by trogocytosis from ovarian tumor cells. For complete details on the use and execution of this protocol, please refer to Gonzalez et al. (2021).
Pubmed ID: 35693208 RIS Download
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
This unknown targets CD56
View all literature mentionsThis monoclonal targets CD16
View all literature mentionsThis monoclonal targets CD7
View all literature mentionsThis monoclonal targets CD14
View all literature mentionsThis monoclonal targets CD19
View all literature mentionsThis unknown targets CD3
View all literature mentionsThis monoclonal targets CD11c
View all literature mentionsThis monoclonal targets
View all literature mentionsThis monoclonal targets CD45
View all literature mentionsThis unknown targets CD45
View all literature mentionsThis monoclonal targets CD9
View all literature mentionsThis monoclonal targets phycoerythrin
View all literature mentionsCell line NK-92 is a Cancer cell line with a species of origin Homo sapiens
View all literature mentionsCell line NKL is a Cancer cell line with a species of origin Homo sapiens (Human)
View all literature mentions